296
Participants
Start Date
June 30, 2012
Primary Completion Date
August 31, 2013
Study Completion Date
September 30, 2013
NKTR-181
Placebo
Placebo dosing will be only in the double-blind randomization arm and will be identical in form to the Experimental NKTR-181
Investigator Site - Duncansville, Duncansville
Investigator Site - Philadelphia, Philadelphia
Investigator Site - Greensboro, Greensboro
Investigator Site - Charleston, Charleston
Investigator Site - Pembroke Pines, Pembroke Pines
Investigator Site - Coral Gables, Coral Gables
Investigator Site - Weston, Weston
Investigator Site - West Palm Beach, West Palm Beach
Investigator Site - Fort Meyers, Fort Myers
Investigator Site - Mobile, Mobile
Investigator Site - Louisville, Louisville
Investigator Site - Cincinnati, Cincinnati
Investigator Site - Evansville, Evansville
Investigator Site - Kenosha, Kenosha
Investigator Site - Kansas City, Kansas City
Investigator Site - Wichita, Wichita
Investigator Site - Omaha, Omaha
Investigator Site - Oklahoma City, Oklahoma City
Investigator Site - Dallas, Dallas
Investigator Site - San Antonio, San Antonio
Investigator Site - San Antonio, San Antonio
Investigator Site - Austin, Austin
Investigator Site - Salt Lake City, Salt Lake City
Investigator Site - Tuscon, Tucson
Investigator Site - Las Vegas, Las Vegas
Investigator Site - Las Vegas, Las Vegas
Investigator Site - Westlake Village, Westlake Village
Investigator Site - San Diego, San Diego
Investigator Site - Garden Grove, Garden Grove
Investigator Site - Walnut Creek, Walnut Creek
Investigator Site - Brockton, Brockton
Investigator Site - Worcester, Worcester
Investigator Site - Berlin, Berlin
Investigator Site - Englewood, Englewood
Lead Sponsor
Nektar Therapeutics
INDUSTRY